Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats

• Main Authors: Apaijai N., Chinda K., Palee S., Chattipakorn S., Chattipakorn N.
• Format: Article
• Language: English
• Published: Public Library of Science 2014
• Online Access: http://www.scopus.com/inward/record.url?eid=2-s2.0-84904540452&partnerID=40&md5=b2b2f6dfe4fc39cfecbdfaedc5688389; http://cmuir.cmu.ac.th/handle/6653943832/995
• Institution: Chiang Mai University

Background: Obese-insulin resistance caused by long-term high-fat diet (HFD) consumption is associated with left ventricular (LV) dysfunction and increased risk of myocardial infarction. Metformin and vildagliptin have been shown to exert cardioprotective effects. However, the effect of these drugs...